<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Oxford Bioscience Partners | Company News & Executive Profiles | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/oxford+bioscience+partners.html?i=3]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Oxford Bioscience Partners]]></description>
	<s:counts start="0" returned="10" found="40" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Safeguard Scientifics and Oxford Bioscience Partners Co-Lead $12 Million Series a Financing for Molecular Biometrics]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Nov_10/ai_n30979964]]></link>
		<description><![CDATA[Company's lead product improves success rate of in vitro fertilization procedure and reduces incidence, risk, and costs of multiple births  WAYNE, Pa. -- Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage technology and life sciences companies, today announced it co-led a $12 million Series...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Nov 2008 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/oxford+bioscience+partners.html"><![CDATA[Oxford Bioscience Partners]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[MIT Enterprise Forum of Cambridge Presents Session on Neuroscience, Featuring Keynote by Dr. Darryle Schoepp, Renowned Drug Discovery Scientist at Merck]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200810/ai_n30946116]]></link>
		<description><![CDATA[On November 12, the  MIT Enterprise Forum of Cambridge , in collaboration with the  McGovern Institute  for Brain Research at MIT, will feature a keynote address by  Dr. Darryle Schoepp , senior vice president and franchise head of neuroscience at  Merck Research Laboratories . Internationally...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 30 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cambridge.html"><![CDATA[Cambridge]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/massachusetts+institute+of+technology.html"><![CDATA[Massachusetts Institute of Technology]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/oxford+bioscience+partners.html"><![CDATA[Oxford Bioscience Partners]]></category>
		<category domain="http://resources.bnet.com/topic/parkinson.html"><![CDATA[Parkinson]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">MRK</category>
	</item>
	<item>
		<title><![CDATA[MicroMed Cardiovascular Purchased and Taken Private by Artificial Heart CEO and Some SynCardia Investors]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Sept_9/ai_n28074209]]></link>
		<description><![CDATA[E-Wilson LLC, Formed by SynCardia CEO Rodger Ford and VP David Mackstaller, is Single Shareholder after Reverse Split on August 25  HOUSTON -- MicroMed Cardiovascular, Inc. (OTCBB:MMCO) ("MicroMed") today announced that it completed all necessary steps and is now private. The final step in the process was a reverse...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 09 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/oxford+bioscience+partners.html"><![CDATA[Oxford Bioscience Partners]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Asterand plc Board Appointment]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Sept_2/ai_n28048543]]></link>
		<description><![CDATA[DETROIT -- Asterand plc (LSE: ATD), a leading provider of human tissue and services to pharmaceutical companies engaged in drug discovery research, announces the appointment of Jonathan J. Fleming as a Non-Executive Director. Mr. Fleming is currently the Managing Partner of Oxford Bioscience Partners (Boston, MA). In addition, the Company...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 02 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[board]]></category>
		<category domain="http://resources.bnet.com/topic/director.html"><![CDATA[director]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/oxford+bioscience+partners.html"><![CDATA[Oxford Bioscience Partners]]></category>
	</item>
	<item>
		<title><![CDATA[Dicerna Pharmaceuticals, a Second Generation RNA Interference Company, Completes Second Closing of Series A Financing; Unveils Strategic Focus]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_July_15/ai_n27912874]]></link>
		<description><![CDATA[- Company Adds New Investor Abingworth -  CAMBRIDGE, Mass. -- Dicerna Pharmaceuticals, Inc. (www.dicerna.com), an RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology[TM], today announced a second closing of its Series A financing, receiving a total of $8.4 million in additional venture capital from new investor...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 15 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/oxford+bioscience+partners.html"><![CDATA[Oxford Bioscience Partners]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Prana Biotechnology to Co-Host Expert Panel Discussion]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200712/ai_n21136356]]></link>
		<description><![CDATA[Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that the Company will host a panel discussion, in conjunction with Rodman and Renshaw, Oxford BioScience Partners, and other distinguished medical and scientific experts, at Oxford BioScience...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 05 Dec 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/oxford+bioscience+partners.html"><![CDATA[Oxford Bioscience Partners]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Xencor Expands Series E Financing to $60 Million]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_25/ai_n27421149]]></link>
		<description><![CDATA[MONROVIA, Calif. -- Xencor, a company developing protein and antibody therapeutics, today announced that it raised an additional $15 million in an extension of its Series E financing, bringing the total raised in this round to $60 million. The first closing of $45 million occurred in October 2006. New investors,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 25 Oct 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/merlin.html"><![CDATA[Merlin]]></category>
		<category domain="http://resources.bnet.com/topic/oxford+bioscience+partners.html"><![CDATA[Oxford Bioscience Partners]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Oxford Bioscience Partners Promotes Dr. Douglas Fambrough to General Partner]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Sept_19/ai_n27378774]]></link>
		<description><![CDATA[BOSTON -- Oxford Bioscience Partners is pleased to announce that Dr. Douglas Fambrough has been promoted to the position of General Partner. Dr. Fambrough has been involved with a series of Oxford portfolio company investments that have created value both for investors as well as for society at large through...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 19 Sep 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/oxford+bioscience+partners.html"><![CDATA[Oxford Bioscience Partners]]></category>
	</item>
	<item>
		<title><![CDATA[Intechra lands $30 million in equity capital]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0KWH/is_8_45/ai_n19492918]]></link>
		<description><![CDATA[Intechra Holding Corp., Jackson, Miss., has secured $30 million in new equity funding from Richland Ventures of Nashville, Oxford Bioscience Partners of Boston and First Avenue Partners of Nashville.  Intechra says it plans to use the funds to support its growth strategy.  "Our clients are demanding an expanded...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Aug 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/equity.html"><![CDATA[equity]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nashville.html"><![CDATA[Nashville]]></category>
		<category domain="http://resources.bnet.com/topic/oxford+bioscience+partners.html"><![CDATA[Oxford Bioscience Partners]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Intechra Secures Additional $30 Million in Equity Capital]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_May_22/ai_n27248145]]></link>
		<description><![CDATA[JACKSON, Miss. -- Electronics lifecycle management company Intechra Holding Corp. today announced that the company has secured $30 million in new equity funding led by Richland Ventures of Nashville, Oxford Bioscience Partners of Boston and First Avenue Partners of Nashville.  Intechra is using the investment primarily to fund acquisitions...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 22 May 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/electronics.html"><![CDATA[electronics]]></category>
		<category domain="http://resources.bnet.com/topic/equity.html"><![CDATA[equity]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nashville.html"><![CDATA[Nashville]]></category>
		<category domain="http://resources.bnet.com/topic/oxford+bioscience+partners.html"><![CDATA[Oxford Bioscience Partners]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
